Magnesium in PDB 4qlu: Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 9
Enzymatic activity of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 9
All present enzymatic activity of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 9:
3.4.25.1;
Protein crystallography data
The structure of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 9, PDB code: 4qlu
was solved by
G.De Bruin,
E.Huber,
B.Xin,
E.Van Rooden,
K.Al-Ayed,
K.Kim,
A.Kisselev,
C.Driessen,
G.Van Der Marel,
M.Groll,
H.Overkleeft,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
15.00 /
2.80
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
134.880,
299.380,
144.830,
90.00,
112.78,
90.00
|
R / Rfree (%)
|
22.3 /
24.8
|
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 9
(pdb code 4qlu). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 8 binding sites of Magnesium where determined in the
Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 9, PDB code: 4qlu:
Jump to Magnesium binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
Magnesium binding site 1 out
of 8 in 4qlu
Go back to
Magnesium Binding Sites List in 4qlu
Magnesium binding site 1 out
of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 9
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 1 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 9 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
G:Mg301
b:40.1
occ:1.00
|
O
|
G:MET125
|
2.1
|
23.0
|
1.0
|
O
|
G:ARG122
|
2.4
|
48.6
|
1.0
|
O
|
G:TYR119
|
2.5
|
41.1
|
1.0
|
OG1
|
G:THR8
|
2.8
|
35.9
|
1.0
|
CG2
|
G:THR8
|
3.2
|
32.5
|
1.0
|
C
|
G:MET125
|
3.3
|
44.1
|
1.0
|
O
|
G:ALA123
|
3.5
|
47.7
|
1.0
|
C
|
G:ARG122
|
3.5
|
47.1
|
1.0
|
CB
|
G:THR8
|
3.6
|
34.5
|
1.0
|
C
|
G:ALA123
|
3.7
|
47.6
|
1.0
|
CA
|
G:ALA123
|
3.7
|
45.4
|
1.0
|
C
|
G:TYR119
|
3.7
|
39.7
|
1.0
|
N
|
G:MET125
|
4.0
|
45.8
|
1.0
|
N
|
G:ALA123
|
4.1
|
46.3
|
1.0
|
CA
|
G:MET125
|
4.2
|
46.4
|
1.0
|
N
|
G:ARG126
|
4.2
|
41.7
|
1.0
|
CA
|
G:ARG126
|
4.3
|
41.4
|
1.0
|
N
|
G:THR8
|
4.3
|
37.0
|
1.0
|
CA
|
G:TYR119
|
4.4
|
39.0
|
1.0
|
N
|
G:TYR124
|
4.5
|
50.8
|
1.0
|
CA
|
G:THR8
|
4.6
|
37.1
|
1.0
|
CB
|
G:MET125
|
4.7
|
54.3
|
1.0
|
CA
|
G:ARG122
|
4.8
|
48.1
|
1.0
|
N
|
G:ARG122
|
4.8
|
42.4
|
1.0
|
N
|
G:THR120
|
4.8
|
38.1
|
1.0
|
CD
|
G:PRO127
|
4.8
|
36.9
|
1.0
|
C
|
G:TYR124
|
4.8
|
45.6
|
1.0
|
C
|
G:ARG126
|
4.9
|
41.2
|
1.0
|
CB
|
G:TYR119
|
4.9
|
41.6
|
1.0
|
CA
|
G:THR120
|
5.0
|
39.0
|
1.0
|
|
Magnesium binding site 2 out
of 8 in 4qlu
Go back to
Magnesium Binding Sites List in 4qlu
Magnesium binding site 2 out
of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 9
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 2 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 9 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
H:Mg301
b:64.2
occ:1.00
|
OD1
|
N:ASP51
|
2.4
|
42.5
|
1.0
|
O
|
H:HOH412
|
2.7
|
39.6
|
1.0
|
OE1
|
H:GLN91
|
2.9
|
57.9
|
1.0
|
CG
|
N:ASP51
|
3.3
|
44.1
|
1.0
|
NE2
|
H:GLN91
|
3.4
|
60.6
|
1.0
|
CD
|
H:GLN91
|
3.5
|
57.6
|
1.0
|
OD2
|
N:ASP51
|
3.6
|
47.3
|
1.0
|
O
|
N:ASN92
|
3.7
|
51.0
|
1.0
|
CE1
|
H:PHE88
|
3.9
|
24.8
|
1.0
|
CZ
|
H:PHE88
|
4.0
|
25.2
|
1.0
|
CB
|
N:ASP51
|
4.7
|
43.2
|
1.0
|
CD1
|
H:PHE88
|
4.7
|
25.2
|
1.0
|
C
|
N:ASN92
|
4.9
|
49.1
|
1.0
|
CG
|
H:GLN91
|
4.9
|
54.0
|
1.0
|
CE2
|
H:PHE88
|
4.9
|
25.3
|
1.0
|
|
Magnesium binding site 3 out
of 8 in 4qlu
Go back to
Magnesium Binding Sites List in 4qlu
Magnesium binding site 3 out
of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 9
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 3 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 9 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
I:Mg301
b:54.9
occ:1.00
|
O
|
I:ALA174
|
2.9
|
40.5
|
1.0
|
O
|
I:ASP177
|
3.0
|
44.3
|
1.0
|
O
|
I:HOH402
|
3.1
|
40.7
|
1.0
|
O
|
I:SER180
|
3.2
|
43.7
|
1.0
|
OXT
|
I:ASP204
|
3.4
|
52.1
|
1.0
|
C
|
I:ALA174
|
3.8
|
42.9
|
1.0
|
CA
|
I:ASP175
|
3.9
|
42.5
|
1.0
|
C
|
I:ASP177
|
4.1
|
44.5
|
1.0
|
C
|
I:ASP175
|
4.2
|
42.1
|
1.0
|
O
|
I:ASP175
|
4.2
|
42.3
|
1.0
|
N
|
I:ASP175
|
4.2
|
42.2
|
1.0
|
C
|
I:ASP204
|
4.3
|
49.9
|
1.0
|
NH2
|
Y:ARG19
|
4.3
|
54.5
|
1.0
|
C
|
I:SER180
|
4.4
|
47.3
|
1.0
|
O
|
I:ASP204
|
4.4
|
52.0
|
1.0
|
OD1
|
I:ASP175
|
4.6
|
52.7
|
1.0
|
N
|
I:ASP177
|
4.6
|
44.0
|
1.0
|
NH1
|
Y:ARG19
|
4.7
|
58.6
|
1.0
|
CA
|
I:ALA178
|
4.8
|
42.4
|
1.0
|
N
|
I:ALA178
|
4.8
|
43.7
|
1.0
|
O
|
I:ALA178
|
4.8
|
41.2
|
1.0
|
OD1
|
I:ASP204
|
4.8
|
47.2
|
1.0
|
CA
|
I:GLY181
|
4.9
|
45.3
|
1.0
|
CZ
|
Y:ARG19
|
4.9
|
53.7
|
1.0
|
C
|
I:ALA178
|
5.0
|
41.6
|
1.0
|
CA
|
I:ASP177
|
5.0
|
45.6
|
1.0
|
N
|
I:ARG176
|
5.0
|
41.6
|
1.0
|
|
Magnesium binding site 4 out
of 8 in 4qlu
Go back to
Magnesium Binding Sites List in 4qlu
Magnesium binding site 4 out
of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 9
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 4 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 9 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
K:Mg301
b:52.8
occ:1.00
|
O
|
W:ASP204
|
2.1
|
49.2
|
1.0
|
O
|
K:ASP168
|
2.2
|
48.6
|
1.0
|
O
|
K:SER171
|
2.4
|
42.6
|
1.0
|
O
|
K:ALA165
|
2.5
|
39.2
|
1.0
|
C
|
W:ASP204
|
3.1
|
51.4
|
1.0
|
C
|
K:ASP168
|
3.3
|
44.1
|
1.0
|
C
|
K:ALA165
|
3.6
|
41.1
|
1.0
|
CA
|
W:ASP204
|
3.6
|
49.6
|
1.0
|
C
|
K:SER171
|
3.6
|
44.2
|
1.0
|
NH1
|
K:ARG19
|
3.6
|
53.2
|
1.0
|
CA
|
K:ALA169
|
3.7
|
41.2
|
1.0
|
O
|
K:ALA169
|
3.8
|
43.3
|
1.0
|
C
|
K:ALA169
|
3.8
|
42.9
|
1.0
|
CB
|
W:ASP204
|
3.9
|
51.3
|
1.0
|
N
|
K:ALA169
|
3.9
|
41.7
|
1.0
|
O
|
K:HIS166
|
4.0
|
38.1
|
1.0
|
OXT
|
W:ASP204
|
4.1
|
51.8
|
1.0
|
CZ
|
K:ARG19
|
4.1
|
54.0
|
1.0
|
N
|
K:SER171
|
4.2
|
40.3
|
1.0
|
CA
|
K:ALA165
|
4.4
|
41.4
|
1.0
|
NH2
|
K:ARG19
|
4.4
|
55.8
|
1.0
|
C
|
K:HIS166
|
4.4
|
39.3
|
1.0
|
CA
|
K:SER171
|
4.5
|
41.5
|
1.0
|
CA
|
K:ASP168
|
4.5
|
43.6
|
1.0
|
N
|
K:HIS166
|
4.5
|
41.5
|
1.0
|
N
|
K:GLY172
|
4.6
|
46.7
|
1.0
|
N
|
K:TYR170
|
4.6
|
42.1
|
1.0
|
CA
|
K:GLY172
|
4.6
|
46.9
|
1.0
|
N
|
K:ASP168
|
4.6
|
42.6
|
1.0
|
O
|
K:ALA164
|
4.7
|
44.7
|
1.0
|
CA
|
K:HIS166
|
4.7
|
40.5
|
1.0
|
CG
|
W:ASP204
|
4.9
|
51.1
|
1.0
|
NE
|
K:ARG19
|
4.9
|
53.4
|
1.0
|
|
Magnesium binding site 5 out
of 8 in 4qlu
Go back to
Magnesium Binding Sites List in 4qlu
Magnesium binding site 5 out
of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 9
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 5 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 9 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
N:Mg201
b:38.7
occ:1.00
|
O
|
N:ILE163
|
2.2
|
41.6
|
1.0
|
O
|
N:SER169
|
2.6
|
40.6
|
1.0
|
O
|
N:ASP166
|
2.9
|
43.5
|
1.0
|
C
|
N:ILE163
|
3.3
|
40.2
|
1.0
|
CD1
|
a:LEU34
|
3.7
|
36.7
|
1.0
|
CG2
|
N:ILE163
|
3.7
|
35.7
|
1.0
|
C
|
N:SER169
|
3.8
|
38.6
|
1.0
|
C
|
N:ASP166
|
3.9
|
39.1
|
1.0
|
CA
|
N:ILE163
|
4.0
|
39.7
|
1.0
|
NH1
|
N:ARG19
|
4.1
|
35.9
|
1.0
|
CA
|
N:GLY170
|
4.3
|
40.0
|
1.0
|
CA
|
N:GLY167
|
4.3
|
36.5
|
1.0
|
N
|
N:LYS164
|
4.4
|
41.3
|
1.0
|
N
|
N:GLY170
|
4.5
|
40.4
|
1.0
|
CB
|
N:ILE163
|
4.5
|
37.6
|
1.0
|
N
|
N:GLY167
|
4.5
|
36.6
|
1.0
|
CA
|
N:LYS164
|
4.6
|
42.6
|
1.0
|
C
|
N:LYS164
|
4.6
|
43.1
|
1.0
|
O
|
N:LYS164
|
4.6
|
47.3
|
1.0
|
CZ
|
N:ARG19
|
4.6
|
35.5
|
1.0
|
O
|
N:GLY167
|
4.8
|
36.9
|
1.0
|
C
|
N:GLY167
|
4.8
|
37.3
|
1.0
|
CG
|
a:LEU34
|
4.8
|
36.7
|
1.0
|
CA
|
N:SER169
|
4.9
|
36.1
|
1.0
|
NH2
|
N:ARG19
|
4.9
|
31.1
|
1.0
|
N
|
N:ASP166
|
4.9
|
36.6
|
1.0
|
N
|
N:SER169
|
4.9
|
37.8
|
1.0
|
|
Magnesium binding site 6 out
of 8 in 4qlu
Go back to
Magnesium Binding Sites List in 4qlu
Magnesium binding site 6 out
of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 9
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 6 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 9 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
V:Mg301
b:67.6
occ:1.00
|
OXT
|
L:ASP222
|
2.2
|
52.8
|
1.0
|
O
|
V:ILE163
|
2.4
|
44.0
|
1.0
|
O
|
V:ASP166
|
2.5
|
45.4
|
1.0
|
O
|
V:TRP164
|
3.0
|
54.6
|
1.0
|
C
|
L:ASP222
|
3.0
|
56.6
|
1.0
|
C
|
V:ASP166
|
3.1
|
44.1
|
1.0
|
C
|
V:TRP164
|
3.3
|
49.3
|
1.0
|
C
|
V:ILE163
|
3.4
|
41.8
|
1.0
|
O
|
V:SER169
|
3.4
|
39.2
|
1.0
|
N
|
V:ASP166
|
3.6
|
42.7
|
1.0
|
CA
|
L:ASP222
|
3.8
|
56.8
|
1.0
|
O
|
L:ASP222
|
3.8
|
59.4
|
1.0
|
N
|
V:LEU167
|
3.8
|
44.2
|
1.0
|
CA
|
V:TRP164
|
3.9
|
48.0
|
1.0
|
O
|
V:GLY162
|
3.9
|
41.2
|
1.0
|
CA
|
V:LEU167
|
4.0
|
43.5
|
1.0
|
N
|
V:ASN165
|
4.0
|
46.1
|
1.0
|
CA
|
V:ASP166
|
4.0
|
41.9
|
1.0
|
N
|
V:TRP164
|
4.0
|
46.0
|
1.0
|
C
|
V:ASN165
|
4.3
|
43.4
|
1.0
|
O
|
L:ARG221
|
4.5
|
54.0
|
1.0
|
CA
|
V:ILE163
|
4.5
|
37.7
|
1.0
|
CA
|
V:ASN165
|
4.5
|
45.7
|
1.0
|
C
|
V:SER169
|
4.6
|
38.6
|
1.0
|
CD2
|
V:LEU167
|
4.6
|
36.7
|
1.0
|
CB
|
L:ASP222
|
4.6
|
57.0
|
1.0
|
NH1
|
V:ARG19
|
4.7
|
49.6
|
1.0
|
CD1
|
L:ILE35
|
4.7
|
51.5
|
1.0
|
C
|
V:LEU167
|
4.8
|
44.0
|
1.0
|
N
|
L:ASP222
|
4.9
|
55.5
|
1.0
|
C
|
V:GLY162
|
4.9
|
36.8
|
1.0
|
|
Magnesium binding site 7 out
of 8 in 4qlu
Go back to
Magnesium Binding Sites List in 4qlu
Magnesium binding site 7 out
of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 9
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 7 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 9 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
Y:Mg301
b:36.7
occ:1.00
|
O
|
I:ASP204
|
2.2
|
52.0
|
1.0
|
O
|
Y:ASP168
|
2.2
|
45.6
|
1.0
|
O
|
Y:SER171
|
2.4
|
44.2
|
1.0
|
O
|
Y:HOH401
|
2.5
|
33.2
|
1.0
|
O
|
Y:ALA165
|
2.7
|
43.6
|
1.0
|
C
|
I:ASP204
|
3.2
|
49.9
|
1.0
|
C
|
Y:ASP168
|
3.3
|
45.4
|
1.0
|
NH1
|
Y:ARG19
|
3.4
|
58.6
|
1.0
|
CA
|
Y:ALA169
|
3.5
|
41.8
|
1.0
|
O
|
Y:ALA169
|
3.6
|
42.1
|
1.0
|
C
|
Y:ALA169
|
3.6
|
43.5
|
1.0
|
C
|
Y:SER171
|
3.6
|
43.5
|
1.0
|
N
|
Y:ALA169
|
3.8
|
44.5
|
1.0
|
CA
|
I:ASP204
|
3.8
|
47.6
|
1.0
|
C
|
Y:ALA165
|
3.8
|
44.3
|
1.0
|
CZ
|
Y:ARG19
|
4.0
|
53.7
|
1.0
|
CB
|
I:ASP204
|
4.1
|
45.6
|
1.0
|
N
|
Y:SER171
|
4.1
|
39.1
|
1.0
|
OXT
|
I:ASP204
|
4.2
|
52.1
|
1.0
|
O
|
Y:HIS166
|
4.2
|
50.9
|
1.0
|
NH2
|
Y:ARG19
|
4.3
|
54.5
|
1.0
|
N
|
Y:TYR170
|
4.4
|
44.9
|
1.0
|
CA
|
Y:SER171
|
4.5
|
39.9
|
1.0
|
CA
|
Y:ASP168
|
4.5
|
44.1
|
1.0
|
CA
|
Y:ALA165
|
4.6
|
41.0
|
1.0
|
N
|
Y:GLY172
|
4.6
|
47.2
|
1.0
|
C
|
Y:HIS166
|
4.7
|
50.6
|
1.0
|
CA
|
Y:GLY172
|
4.7
|
48.8
|
1.0
|
N
|
Y:ASP168
|
4.7
|
42.9
|
1.0
|
NE
|
Y:ARG19
|
4.8
|
52.6
|
1.0
|
N
|
Y:HIS166
|
4.8
|
47.2
|
1.0
|
O
|
Y:ALA164
|
4.9
|
45.1
|
1.0
|
CB
|
Y:ALA169
|
4.9
|
39.5
|
1.0
|
CA
|
Y:HIS166
|
5.0
|
48.9
|
1.0
|
|
Magnesium binding site 8 out
of 8 in 4qlu
Go back to
Magnesium Binding Sites List in 4qlu
Magnesium binding site 8 out
of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 9
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 8 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 9 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
Z:Mg301
b:71.3
occ:1.00
|
O
|
Z:VAL198
|
2.7
|
42.5
|
1.0
|
O
|
Z:THR192
|
3.0
|
47.5
|
1.0
|
O
|
Z:ASP222
|
3.1
|
65.3
|
1.0
|
O
|
Z:HIS195
|
3.2
|
46.4
|
1.0
|
NH2
|
Z:ARG28
|
3.4
|
65.9
|
1.0
|
O
|
Z:ILE196
|
3.8
|
50.1
|
1.0
|
OD1
|
Z:ASP222
|
3.9
|
68.8
|
1.0
|
C
|
Z:VAL198
|
3.9
|
42.6
|
1.0
|
NH2
|
H:ARG19
|
3.9
|
60.4
|
1.0
|
CG2
|
Z:THR192
|
4.0
|
43.5
|
1.0
|
C
|
Z:THR192
|
4.0
|
48.1
|
1.0
|
CA
|
Z:ILE196
|
4.1
|
41.5
|
1.0
|
C
|
Z:ASP222
|
4.2
|
71.4
|
1.0
|
C
|
Z:ILE196
|
4.2
|
42.6
|
1.0
|
C
|
Z:HIS195
|
4.2
|
43.8
|
1.0
|
CZ
|
Z:ARG28
|
4.4
|
67.2
|
1.0
|
CA
|
Z:THR192
|
4.4
|
47.1
|
1.0
|
NH1
|
Z:ARG28
|
4.6
|
70.4
|
1.0
|
CA
|
Z:GLY199
|
4.6
|
40.1
|
1.0
|
N
|
Z:ILE196
|
4.7
|
42.1
|
1.0
|
OXT
|
Z:ASP222
|
4.7
|
66.4
|
1.0
|
N
|
Z:GLY199
|
4.7
|
40.7
|
1.0
|
N
|
Z:VAL198
|
4.7
|
42.4
|
1.0
|
NH1
|
H:ARG19
|
4.7
|
58.7
|
1.0
|
CZ
|
H:ARG19
|
4.7
|
57.9
|
1.0
|
CG
|
Z:ASP222
|
4.8
|
65.7
|
1.0
|
CB
|
Z:THR192
|
4.8
|
44.5
|
1.0
|
O
|
Z:LYS220
|
4.8
|
55.5
|
1.0
|
CA
|
Z:VAL198
|
4.9
|
41.8
|
1.0
|
|
Reference:
G.De Bruin,
E.M.Huber,
B.T.Xin,
E.J.Van Rooden,
K.Al-Ayed,
K.B.Kim,
A.F.Kisselev,
C.Driessen,
M.Van Der Stelt,
G.A.Van Der Marel,
M.Groll,
H.S.Overkleeft.
Structure-Based Design of Beta 1I or Beta 5I Specific Inhibitors of Human Immunoproteasomes J.Med.Chem. V. 57 6197 2014.
ISSN: ISSN 0022-2623
PubMed: 25006746
DOI: 10.1021/JM500716S
Page generated: Tue Aug 20 02:05:11 2024
|